Penserra Capital Management LLC Rocket Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$21.52 - $36.02 $31,311 - $52,409	-1,455 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $274 - $489	10 Added 0.69%	1,455 $43,000
Q2 2021 Aug 12, 2021	BUY	$39.41 - $47.25 $2,955 - $3,543	75 Added 5.47%	1,445 $63,000
Q1 2021 May 13, 2021	BUY	$43.34 - $65.91 $4,117 - $6,261	95 Added 7.45%	1,370 $60,000
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $18,709 - $47,834	803 Added 170.13%	1,275 $69,000
Q3 2020 Nov 13, 2020	BUY	$20.5 - $28.59 $9,676 - $13,494	472 New	472 $10,000

244

108M

262K

159K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $632M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.